Statins failing adequately to reduce cholesterol in 'half' of patients


Statins are failing adequately to reduce cholesterol in more than half of patients, a major review has found.

Experts have called for an end to “blanket” prescribing and for better methods of predicting which patients will respond to the drugs after new figures showed millions are not meeting the official cholesterol reduction target.

The National Institute of Health and Care Excellence (Nice) stipulates that patients should see a reduction in “bad” low-density cholesterol of at least 40 per cent within two years of starting on the daily pills.

However, the “alarming” new study, published in the BMJ publication Heart, revealed that, typically, 51 per cent fail to achieve this improvement.



Please enter your comment!
Please enter your name here